ArticleBMC neurology2026
Monocyte-to-high-density lipoprotein cholesterol ratio predicts hematoma expansion and poor outcomes in patients with spontaneous intracerebral hemorrhage.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the predictive capacity of the monocyte-to-high-density lipoprotein cholesterol ratio (MHR) for functional outcomes in patients with spontaneous intracerebral hemorrhage (ICH).
methodsIn the present study, adult patients with ICH admitted to the affiliated hospital of Southwest Medical University between January 2020 and January 2024 were recruited. We collected the clinical, imaging, as well as laboratory test data of patients. Information of hematoma expansion (HE) after ICH onset was obtained, and modified Rankin scale (mRS) scores were applied to assess the clinical outcomes. Multivariable logistic regression models were used to evaluate the association of MHR with HE and clinical outcomes in ICH patients. Receiver operating characteristic (ROC) curve analysis was carried out to determine the optimal cutoff of MHR to predict HE after ICH onset.
resultsWe included 541 patients with ICH in our investigation. Multivariate logistic regression analysis showed that higher MHR on admission was an independent predictor of HE (p = 0.047). ROC analysis determined 0.275 as the optimal MHR cutoff point for HE prediction. Moreover, multivariate regression analysis demonstrated that MHR ≥ 0.275 was strongly associated with poor one-year prognosis in ICH patients (p = 0.033).
conclusionsHigher MHR is closely correlated with elevated risks of HE and unfavorable ICH prognosis. Our data reveal that MHR could serve as an effective prognostic indicator for ICH. However, due to limitations such as potential selection bias and a modest predictive performance, external validation in a multicenter, large-scale prospective study is needed before MHR's clinical utility can be established.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.